SEZL vs. ZVRA
SEZL (Sezzle Inc. Common Stock) and ZVRA (Zevra Therapeutics Inc.) are both stocks. SEZL operates in Credit Services (Financial Services), while ZVRA operates in Biotechnology (Healthcare). Over the past year, SEZL returned -5.28% vs 35.01% for ZVRA. At a 0.17 correlation, their price movements are largely independent.
Performance
SEZL vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SEZL achieves a 109.06% return, which is significantly higher than ZVRA's 41.18% return.
SEZL
- 1D
- 3.00%
- 1M
- 29.59%
- YTD
- 109.06%
- 6M
- 88.63%
- 1Y
- -5.28%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ZVRA
- 1D
- -2.47%
- 1M
- 13.76%
- YTD
- 41.18%
- 6M
- 51.86%
- 1Y
- 35.01%
- 3Y*
- 29.54%
- 5Y*
- -2.85%
- 10Y*
- -16.40%
SEZL vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
SEZL Sezzle Inc. Common Stock | 109.06% | 48.89% | 1,146.59% | -9.40% |
ZVRA Zevra Therapeutics Inc. | 41.18% | 7.43% | 27.33% | 26.20% |
Correlation
The correlation between SEZL and ZVRA is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Aug 17, 2023 | 0.17 |
Fundamentals
SEZL:
$4.64B
ZVRA:
$761.92M
SEZL:
$4.15
ZVRA:
$2.16
SEZL:
32.00
ZVRA:
5.85
SEZL:
9.87
ZVRA:
5.94
SEZL:
23.56
ZVRA:
3.70
SEZL:
$480.91M
ZVRA:
$122.29M
SEZL:
$426.79M
ZVRA:
$104.94M
SEZL:
$193.18M
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SEZL vs. ZVRA — Risk / Return Rank
SEZL
ZVRA
SEZL vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sezzle Inc. Common Stock (SEZL) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SEZL | ZVRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.62 | ||
| Sortino ratioReturn per unit of downside risk | -0.71 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.16 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.07 | 0.81 | -0.88 |
| Martin ratioReturn relative to average drawdown | -0.10 | 1.41 | -1.51 |
Loading charts...
Drawdowns
SEZL vs. ZVRA - Drawdown Comparison
The maximum SEZL drawdown since its inception was -89.95%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for SEZL and ZVRA.
Loading charts...
Drawdown Indicators
| SEZL | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.95% | -99.27% | +9.32% |
Max Drawdown (1Y)Largest decline over 1 year | -72.02% | -43.47% | -28.55% |
Max Drawdown (3Y)Largest decline over 3 years | — | -43.47% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -74.01% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.85% | — |
Current DrawdownCurrent decline from peak | -27.15% | -96.65% | +69.50% |
Average DrawdownAverage peak-to-trough decline | -40.29% | -86.41% | +46.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 53.61% | 24.87% | +28.74% |
Volatility
SEZL vs. ZVRA - Volatility Comparison
The current volatility for Sezzle Inc. Common Stock (SEZL) is 17.41%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 24.56%. This indicates that SEZL experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SEZL | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.41% | 24.56% | -7.15% |
Volatility (6M)Calculated over the trailing 6-month period | 62.20% | 40.23% | +21.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.49% | 62.90% | +24.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 204.57% | 60.49% | +144.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 204.57% | 81.46% | +123.11% |
Dividends
SEZL vs. ZVRA - Dividend Comparison
Neither SEZL nor ZVRA has paid dividends to shareholders.
Financials
SEZL vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between Sezzle Inc. Common Stock and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SEZL and ZVRA have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (24.56%) compared to SEZL (17.41%). In terms of maximum drawdown, SEZL dropped -89.95% vs ZVRA's -99.27%.
ZVRA currently has the higher Sharpe Ratio (0.56 vs -0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SEZL and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer